Equity
€43,132 from €395,265 in 2023
Equity fell by 89% in 2 years.
Dr. D. Raymakers
Lifetime
5 annual accounts with figures on one time axispeak €264,636 (2023)
€248,683▲ 1.4%
peak €187,150 (2023)
€181,887▲ 6.5%
peak €395,265 (2023)
€43,132▼ 6.7%
€203,231▼ 32.6%
Board2 names since 2020
2 directors and 1 other
Documentsfilings and deeds
16-12-202546 days before the deadline
2025micro format
Dividend €185,000Debts from €301,452 to €203,231Cash from €314,740 to €208,555
Key points
from the 2025 annual accountsTurnover
≈ €460,000 estimated
The accounts state no turnover.
Debts
€203,231 82% of the balance sheet
Suppliers 5%Taxes and wages 2%Other 94%
Of this, €202,465 falls due within a year.
Filings
5 annual accounts since 2021
The last five annual accounts were filed 31 to 46 days before the end of the period.
Starting capital
€25,000 250 shares
Position in the sector
17.5%
Lower solvency than 81% of companies in human health. Sector median 63.1% · 21,322 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,715 companies had the same profile as Dr. D. Raymakers has now. Each dot stands for 17 companies, two years later.
95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,715 companies, not a prediction for Dr. D. Raymakers. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Reappointment: (director)
General meeting of 03-08-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0752617258
Appointment: (director)
General meeting of 26-02-2021 · Gazette deed
Incorporation
Founding capital of €25,000, 250 shares · Founder: · Appointment: (director) · published on 18-08-2020 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Dr. D. Raymakers Lummen | €246,363 | €248,683 | 17.5% | - |
| Vercomed Alken | €274,269 | €263,189 | 70.3% | - |
| Dr. Carolien Vanholst Oogarts Genk | €217,272 | €238,286 | 21.8% | 0 |
| Dr. Annemijn Witdouck, anesthesie Hasselt | €264,009 | €280,069 | 83.2% | - |
| INDOLORIS Saint-Josse-ten-Noode | €258,141 | €247,103 | 15.3% | - |
| Dr. Anneke van der Leden Pathologie Antwerp | €229,317 | €236,162 | 98.9% | - |
| Dr. Els Deklerck Oostkamp | €245,697 | €270,591 | 91.0% | - |
These companies have the same main activity as Dr. D. Raymakers: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €217,000 and €274,000, founded in 2020.
Official details
Source: KBO- Status
- Active since 14-08-2020Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.305.887.5623800 Sint-Truiden, since 14-08-2020
- Financial year end
- 30 June
- Peppol
- Reachable since 04-08-2025
Annual accounts to 30-06-2025
- €246,363▼ 29.1%
- Filing
- Filed on 16-12-2025, 46 days before the end of the filing period
Insights on Dr. D. Raymakers
Dr. D. Raymakers files the micro format. That format states no turnover. The gross margin rose from €90,825 in 2021 to €248,683 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Dr. D. Raymakers
- What is the company number of Dr. D. Raymakers?
- The company number of Dr. D. Raymakers is 0752.617.258. The VAT number is the same number with BE in front: BE 0752.617.258.
- Where is Dr. D. Raymakers based?
- The registered office is at Priesterse Heidestraat 41, 3560 Lummen.Company details
- What does Dr. D. Raymakers do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of Dr. D. Raymakers?
- Dr. D. Raymakers is a private limited company (BV).
- When was Dr. D. Raymakers founded?
- Dr. D. Raymakers was founded on 14-08-2020.
- Is Dr. D. Raymakers still active?
- Yes, Dr. D. Raymakers is an active enterprise in the KBO register.
- What is the turnover of Dr. D. Raymakers?
- The turnover in financial year 2025 is ≈ €460,000. This figure is estimated from the gross margin of €248,683 and 40 comparable companies (NACE 86220). It probably lies between €390,000 and €610,000.Financials
- Is Dr. D. Raymakers profitable?
- In financial year 2025, Dr. D. Raymakers made a profit of €181,887.
- Where can I find the annual accounts of Dr. D. Raymakers?
- Dr. D. Raymakers filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Dr. D. Raymakers due?
- Dr. D. Raymakers must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.